The pathological descriptions of different subtypes of TNETs were shown in Fig. 1, including hematoxylin–eosin staining of tumor, immunocytochemistry staining of neuroendocrine markers (chromogranin A and synaptophysin) and Ki-67. The gene discussed is CHGA; the disease is neoplasm.